Recently, a number of studies have been performed to explore the association between CTLA-4 A49G polymorphism and rheumatoid arthritis (RA). However, the results of previous works are still controversial and ambiguous.
Methods
In this work, we attempted to perform an updated meta-analysis of available case-control study in order to assess the association between CTLA-4 A49G polymorphism and RA risk. We searched the various citation databases without limits on languages. Article searching was performed by screening the references of retrieved studies manually. Odds ratios (OR) and 95% confidence intervals (95% CI) were calculated to evaluate the strength of the association.
Results
We totally compiled 27 studies in 24 articles (9805 RA patients and 10691 control subjects) into our meta-analysis work. We found significant association between CTL-A4 A49G polymorphism and RA risk (GG vs. AA: OR = 1.13, 95% CI = 1.03-1.23; GA vs. AA: OR = 1.19, 95% CI = 1.07-1.33; GA + GG vs. AA: OR = 1.18, 95% CI = 1.07-1.29). In the subgroup analysis by ethnicity, evidences of significantly increased risk was also found in both Asian (GG vs. AA: OR = 1.34, 95% CI = 1.15-1.55; GA + GG vs. AA: OR = 1.24, 95% CI = 1.08-1.41) and Caucasian population (GA vs. AA: OR = 1.19, 95% CI = 1.03-1.37; GA + GG vs. AA: OR = 1.14, 95% CI = 1.01-1.29). No evidence of publication bias was found in this work.
Conclusions
Our meta-analysis suggests that CTLA-4 A49G polymorphism was associated with RA risk.
The online version of this article (doi:10.1186/s13000-014-0157-0) contains supplementary material, which is available to authorized users.
Competing interests
None of the authors have any commercial or other association that might pose a conflict of interest. All authors are responsible for the content and writing of the paper.
Authors' contributions
FS participated in research design. GL, FS, JL and YL selected the articles, GL, FS, JL and YL performed data analysis. The manuscript was drafted by FS, and critically reviewed and discussed with the other co-authors. All the authors read and approved the final manuscript.
Background
Rheumatoid arthritis (RA) is a common chronic inflammatory autoimmune disease characterized by significant disability and early mortality. RA affects ~1% of the adults worldwide [1]. Although its etiology has not been determined, RA has been regarded as a complex autoimmune disorder characterized by a chronic T-cell response. So, genes involved in T-cell response regulation might be important determinants of RA susceptibility.
The cytotoxic T-lymphocyte antigen 4 (CTLA-4) is an inhibitory receptor predominantly expressed on the activated and regulatory T lymphocytes [2]. It plays an important role in regulating T-cell activation. Several studies have documented that polymorphism of CTLA-4 A49G have remarkable effects on the susceptibility to autoimmunity [3]. A49G (rs231775) polymorphism, located in the first exon region of CTLA-4 gene, was identified as a functional single nucleotide polymorphism with a A to G change. This polymorphism has been shown to be associated with the susceptibility of diverse diseases [4]-[8], including RA. The results of previous reports on the possible association of CTLA-4 A49G polymorphism with RA risk remain controversial and ambiguous. To our knowledge, the issue of whether CTLA-4 A49G polymorphism can increase RA risk remains largely uncertain. A comprehensive meta-analysis can provide a reliable estimate in genetic association studies. In this work, we conducted a quantitative meta-analyses that increased statistical power to derive a more precise estimation of the relationship.
Anzeige
Methods
Study identification and selection
A systematic literature search was carried out in the PubMed, IS Web and Chinese National Knowledge Infrastructure (CNKI) database with the terms of "CTLA-4", "rheumatoid arthritis", "polymorphism", "variation". Two investigators independently screened the information including the titles, abstracts and full texts to determine inclusion carefully. No language restrictions were used in our literature search.
Data extraction
The following inclusion criteria were used to select related literatures for the meta-analysis: (1) studies about the association between CTLA-4 A49G polymorphism and RA risk; (2) a case-controlled RA study of CTLA-4 A49G polymorphism with complete genotype distribution data; (3) studies on sufficient data and the original data from case-control studies. The following information were extracted from included studies: first author, year of publication, original country, ethnicity of the sample and genotype distributions.
Statistical analysis
The pooled odds ratios (ORs) with the corresponding 95% confidence intervals (95% CI) were used to evaluate the strength of association between the polymorphism of CTLA-4 A49G and RA risk. Four models were estimated: the co-dominant model (GG vs. AA, GA vs. AA), dominant model (GA + GG vs. AA) and recessive model (GG vs. GA + AA), respectively. Subgroup analyses were performed by ethnicity.
At first, we evaluated the HWE in the controls for each study using chi-square and a P < 0.05 was considered as significant disequilibrium. Statistical heterogeneity among the studies was gauged by the Chi-square based on Q-test. A P value greater than 0.1 for the Q-test indicates no significant heterogeneity existing among studies, and the pooled OR estimation was performed using the fixed-effects model (the Mantel-Haenszel method). Otherwise, the random-effects model (DerSimonian and Laird method) was used. Potential publication bias of literatures was analyzed through the Egger's linear regression test with a funnel plot. All statistical analyses were performed with STATA version 11.0 (Stata Corporation, College Station, TX). All the P values were calculated using a two-sided test and P < 0.05 were considered as statistically significant.
Anzeige
Results
Study characteristics
A total of xx articles were retrieve after the first search in various databases. After literature selection, 43 studies about the association of CTLA-4 A49G polymorphism with RA risk were identified and screened for data retrieval. Among which, 16 studies were irrelevant. At last, a total of 27 eligible independent case-control studies in 24 articles were included [9]-[33]. The characteristics of selected studies are summarized in Table 1. All of the studies indicated that the genotypic distribution of the controls was consistent with Hardy-Weinberg equilibrium.
Table 1
Main characteristics of studies included in our work
First author
Year
Location
Ethnicity
Case/controls
HWE
GG
GA
AA
Seidl
1998
Germany
Caucasian
37/68
138/210
83/179
0.88
Matsushita
1999
Japan
Asian
200/56
199/72
62/22
0.98
Gonzalez-Escribano
1999
Spain
Caucasian
10/30
63/103
65/172
0.06
Barton
2000
Spain
Caucasian
14/12
57/70
65/62
0.44
Yanagawa
2000
Japan
Asian
29/78
50/88
6/34
0.56
Hadj
2001
Tunisia
African
23/68
27/62
10/20
0.33
Milicic
2001
UK
Caucasian
63/73
223/213
135/166
0.94
Lee
2002
Korea
Asian
41/49
35/29
10/8
0.49
Vaidya
2002
UK
Caucasian
20/45
65/158
38/146
0.97
Lee
2003
China
Asian
103/85
67/100
16/18
0.32
Liu
2004
Taiwan
Asian
14/21
42/50
9/10
0.07
Barton
2004
UK
Caucasian
34/29
55/68
43/59
0.49
Lei
2005
China
Asian
148/86
138/125
40/39
0.84
Takeuchi
2006
Japan
Asian
49/44
39/49
12/11
0.88
Suppiah
2006
UK
Caucasian
40/92
144/241
92/142
0.85
Tsukahara
2008
Japan
Asian
636/181
668/194
186/73
0.23
Walker
2009
Canada
Caucasian
177/179
554/576
409/493
0.87
Munoz-Valle
2010
Mexico
Mexican
42/34
102/82
55/83
0.22
Plant (F)
2010
France
Caucasian
96/15
315/75
273/72
0.77
Plant (Ge)
2010
Germany
Caucasian
37/94
111/83
72/83
0.44
Plant (Gr)
2010
Greece
Caucasian
26/33
133/107
113/147
0.15
Plant (U)
2010
UK
Caucasian
146/410
451/1255
407/994
0.91
Benhatchi
2011
Slovakia
Caucasian
6/5
33/25
18/21
0.82
Rocha
2011
Brail
Caucasian
9/3
29/15
32/12
0.86
Tang
2013
China
Asian
652/474
642/535
195/191
0.154
Alfadhli
2013
Kuwait
Asian
10/14
30/86
74/182
0.65
Liu
2013
China
Asian
77/130
111/125
25/48
0.16
Quantitative synthesis
All of the main results of the meta-analysis were shown in Table 2. Overall, significant associations between CTLA-4 A49G polymorphism and RA risk was found (GG vs. AA: OR = 1.13, 95% CI = 1.03-1.23; GA vs. AA: OR = 1.19, 95% CI = 1.07-1.33; GA + GG vs. AA: OR = 1.18, 95% CI = 1.07-1.29) (Figure 1). Next, we performed a further analysis on data stratified by ethnicity groups with the attempt to search for possible factors that might impact the results. In the subgroup analysis by ethnicity, evidences of significantly increased risk was also found in both Asian (GG vs. AA: OR = 1.34, 95% CI = 1.15-1.55; GA + GG vs. AA: OR = 1.24, 95% CI = 1.08-1.41) and Caucasian population (GA vs. AA: OR = 1.19, 95% CI = 1.03-1.37; GA + GG vs. AA: OR = 1.14, 95% CI = 1.01-1.29) in different genetic models.
Table 2
Results of meta-analysis for CTLA-4 A49G polymorphism and RA risk
Groups
GG vs AA
GA vs AA
GA + GG vs AA
GG vs GA + AA
P-value
OR (95% CI)
P-value
OR (95% CI)
P-value
OR (95% CI)
P-value
OR (95% CI)
Total
0.009
1.13 (1.03, 1.23)
0.001
1.19 (1.07, 1.33)
0.001
1.18 (1.07, 1.29)
0.66
1.03 (0.91, 1.17)
Asians
0.001
1.34 (1.15, 1.55)
0.083
1.16 (0.98, 1.37)
0.002
1.24 (1.08, 1.41)
0.099
1.14 (0.97, 1.35)
Caucasian
0.991
1.00 (0.89, 1.12)
0.015
1.19 (1.03, 1.37)
0.042
1.14 (1.01, 1.29)
0.51
0.93 (0.77, 1.14)
Figure 1
Forest plots for the overall association between CTLA-4 A49G polymorphism and RA risk A) GGvs.AA; B) GAvs.AA; C) GA + GGvs.AA; D) GGvs.GA + GG.
×
Heterogeneity analysis
Significant heterogeneity existed in all four genetic models (GG vs. AA: P = 0.016, I2 = 40.7%; GA vs. AA: P = 0.01, I2 = 42.9%; GA + GG vs. AA: P = 0.027, I2 = 37.4%; GG vs. GA + AA: P = 0.00, I2 = 58.2%). Therefore, the random-effect models were employed in all genetic models.
Sensitivity analyses and publication bias
Sensitivity analyses were performed to assess whether each individual study can affect the final results by using Begg's test and Egger's test. Neither the Begg's test nor the Egger's test provided any obvious evidences of publication bias (Table 3). The shapes of the funnel plots appeared to be symmetrical in all genetic models (Figure 2). These results showed that no individual study affected the final results in diverse genetic models using the exclusion method step by step.
Table 3
Results of Egger's test and Begg's test
Comparison
Egger's test
Begg's test
t
P
95% CI
Z
P
GG vs AA
0.31
0.76
(?0.92, 1.25)
0.67
0.51
GA vs AA
1.02
0.32
(?0.54, 1.61)
0.33
0.74
GA + GG vs AA
1.07
0.29
(?0.49, 1.55)
0.67
0.51
GG vs GA + AA
?0.55
0.58
(?1.62, 0.94)
0.08
0.93
Figure 2
Funnel plots for A49G polymorphism of CTLA-4 in RA disease A) GGvs.AA; B) GAvs.AA; C) GA + GGvs.AA; D) GGvs.GA + GG.
×
Discussion
Although many efforts have been devoted for decades, the underlying molecular genetic basis of RA remains largely unknown. Recently, researches in the genetic susceptibility to RA have led to growing attentions to the study of association between gene polymorphisms and RA [34]. Large and well-designed genotype-phenotype investigations with robust statistical technical are required to detect these mild to moderate associations. Up to date, the association studies have been performed for CTLA-4 A49G polymorphism with respect to several disease susceptibility, such as liver disease, pancreatic cancer, primary biliary cirrhosis, etc. [5],[35],[36]. It has been realized that CTLA-4 A49G polymorphism play important role in disease disorders.
Several case-control studies have demonstrated inconsistent and even inverse relationship between CTLA-4 A49G polymorphism and RA risk. Until now, there are still no consensus results on the association of CTLA-4 A49G polymorphism and susceptibility of RA. In this work, we conducted a more comprehensive meta-analysis on the CTLA-4 A49G polymorphism and RA. For the overall data, it has been shown that CTLA-4 A49G polymorphism have an elevated association with RA risk. In the subgroup analysis by ethnicity, results suggested that strong evidences support the association between RA risk and CTLA-4 A49G polymorphism in both Asian and Caucasian populations. Previous meta-analyses works have reported that the CTLA-4 A49G polymorphism is associated with RA risk in Asians, but not in Caucasians using limited data [37],[38]. In our work, we performed an up-dated meta-analyses, and found that A49G polymorphism is associated with RA risk in both Asians and Caucasians.
Many works have been devoted to examine the association between polymorphisms and RA risk [39],[40]. As we know, genetic polymorphism of biomarkers is the key factor leading to the susceptibility of diseases. Our work suggests that CTLA-4 A49G polymorphism might be a potential clinical marker for RA. Important clinical insights are emerging, and this polymorphism provides new understanding of RA diagnostic advances. We provided useful reference for clinical medical treatment. However, there are still some limitations in our meta-analysis work. First, we were not able to take into account other factors because of lacking the original data, such as alcohol addictive, inflammation and other disease that may influence the association estimates; Second, although all eligible studies were summarized, the total sample size might have not been enough to make a convincing conclusion. So, when we performed stratified analysis of ethnicity, the number of each subgroup was relative smaller.
Conclusions
Our meta-analyses provided a more comprehensive evidence of the association between CTLA-4 A49G polymorphism and RA risk. The result showed that CTLA-4 A49G polymorphism is associated with susceptibility of RA.
Anzeige
Acknowledgements
We thanks three anonymous reviewers for their insightful suggestions.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
None of the authors have any commercial or other association that might pose a conflict of interest. All authors are responsible for the content and writing of the paper.
Authors' contributions
FS participated in research design. GL, FS, JL and YL selected the articles, GL, FS, JL and YL performed data analysis. The manuscript was drafted by FS, and critically reviewed and discussed with the other co-authors. All the authors read and approved the final manuscript.
Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …
Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …
Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …
Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …
